Andere Sprachen Themis Medicare Limited

Aktien

A3EYVR

INE083B01024

THEMISMED

Markt geschlossen - Bombay S.E. Andere Börsenplätze 12:01:01 05.06.2024			% 5 Tage	% 1. Jan.
203,2 ^INR	+6,53 %		-1,84 %	-4,53 %

14.05.	Themis Medicare Limited empfiehlt Dividende für das am 31. März 2024 beendete Geschäftsjahr, zahlbar am oder nach dem 22. Juli 2024	CI
14.05.	Themis Medicare Limited berichtet über die Ergebnisse für das am 31. März 2024 endende Geschäftsjahr	CI

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Themis Medicare Limited Recommends Dividend for Financial Year Ended March 31, 2024, Payable on or after July 22, 2024	14.05.
Themis Medicare Limited Reports Earnings Results for the Full Year Ended March 31, 2024	14.05.
Themis Medicare Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2024	14.05.
Themis Medicare Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	10.02.
Themis Medicare Limited Launches REMITHEM	10.11.
Themis Medicare Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	04.11.
Themis Medicare Limited Announces Incorporation of Wholly Owned Subsidiary	20.09.23
Themis Medicare Limited Announces Cessation of Vijay Agarwal as Independent Director	09.09.23
Themis Medicare Limited Appoints Reena Patel as Alternate Non-Executive Non- Non-Independent Director to Dr. Adam Demeter, Effective September 11, 2023	07.09.23
Themis Medicare Limited Reports Earnings Results for the First Quarter Ended June 30, 2023	10.08.23
Themis Medicare Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2023	13.05.23
Themis Medicare Limited Reports Earnings Results for the Full Year Ended March 31, 2023	13.05.23
Themis Medicare Limited Recommends Dividend for Financial Year Ended 31 March 2023	13.05.23
Themis Medicare Limited Announces Board Resignations	02.05.23
Themis Medicare Gets Drug Controller General of India’s No-Objection for Diclofenac Injection	17.02.23
Themis Medicare Announces DCGI Approval of Remifentanil Hydrochloride 1mg/2mg for Injection for Import and Marketing	17.02.23
Themis Medicare Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022	03.02.23
Themis Medicare Launches Drug for Treatment of Menopausal Symptoms in India	04.01.23
Themis Medicare Ltd. Launches Lenzetto Â¡Global Brand of Estradiol Novel Drug Delivery System	03.01.23
Themis Medicare Posts Decline in Fiscal Q2 Consolidated Profit	09.11.22

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Themis Medicare Limited

Aktien

A3EYVR

INE083B01024

THEMISMED

Andere Sprachen

Filter